Back to Search
Start Over
Randomized Evaluation of efficacy and safety of ferric carboxymaltose in Patients with iron deficiency Anaemia and Impaired Renal function (REPAIR-IDA): rationale and study design.
- Source :
- Nephrology Dialysis Transplantation; Jul2010, Vol. 25 Issue 7, p2368-2375, 8p, 1 Diagram, 4 Charts, 1 Graph
- Publication Year :
- 2010
-
Abstract
- Background. Patients with iron deficiency anaemia (IDA) in the setting of non-dialysis-dependent chronic kidney disease (NDD-CKD) may benefit from treatment with intravenous (IV) iron. Ferric carboxymaltose (FCM) is a novel IV iron formulation designed to permit larger infusions compared to currently available IV standards such as Venofer® (iron sucrose). [ABSTRACT FROM PUBLISHER]
Details
- Language :
- English
- ISSN :
- 09310509
- Volume :
- 25
- Issue :
- 7
- Database :
- Complementary Index
- Journal :
- Nephrology Dialysis Transplantation
- Publication Type :
- Academic Journal
- Accession number :
- 51861553
- Full Text :
- https://doi.org/10.1093/ndt/gfq218